Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

The molecular diagnosis and management of thyroid neoplasms.

Theoharis C, Roman S, Sosa JA.

Curr Opin Oncol. 2012 Jan;24(1):35-41. doi: 10.1097/CCO.0b013e32834dcfca. Review.

PMID:
22123232
2.

Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.

Krane JF, Cibas ES, Alexander EK, Paschke R, Eszlinger M.

Cancer Cytopathol. 2015 Jun;123(6):356-61. doi: 10.1002/cncy.21546.

3.

Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule.

Kang G, Cho EY, Shin JH, Chung JH, Kim JW, Oh YL.

Cancer Cytopathol. 2012 Feb 25;120(1):44-51. doi: 10.1002/cncy.20179.

4.

Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules.

Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D, Westra WH.

Clin Cancer Res. 2004 Apr 15;10(8):2761-5.

5.

BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.

Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C.

Acta Cytol. 2011;55(6):570-5. doi: 10.1159/000333274.

PMID:
22156468
6.

Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules.

Musholt TJ, Fottner C, Weber MM, Eichhorn W, Pohlenz J, Musholt PB, Springer E, Schad A.

World J Surg. 2010 Nov;34(11):2595-603. doi: 10.1007/s00268-010-0729-4.

PMID:
20652698
7.

Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.

Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC.

Thyroid. 2011 Jul;21(7):717-23. doi: 10.1089/thy.2011.0021.

PMID:
21568726
8.

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.

Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G, Vitale M.

Clin Endocrinol (Oxf). 2007 May;66(5):678-83.

PMID:
17381488
9.

Molecular diagnostics of thyroid tumors.

Nikiforov YE.

Arch Pathol Lab Med. 2011 May;135(5):569-77. doi: 10.1043/2010-0664-RAIR.1. Review.

PMID:
21526955
10.

Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.

Kim SK, Kim DL, Han HS, Kim WS, Kim SJ, Moon WJ, Oh SY, Hwang TS.

Diagn Mol Pathol. 2008 Jun;17(2):118-25. doi: 10.1097/PDM.0b013e31815d059d.

PMID:
18382358
11.

Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China.

Guo HQ, Zhao H, Zhang ZH, Zhu YL, Xiao T, Pan QJ.

Dis Markers. 2014;2014:912182. doi: 10.1155/2014/912182.

12.

B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules.

Bentz BG, Miller BT, Holden JA, Rowe LR, Bentz JS.

Otolaryngol Head Neck Surg. 2009 May;140(5):709-14. doi: 10.1016/j.otohns.2009.01.007.

PMID:
19393416
13.

Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.

Eszlinger M, Krogdahl A, Münz S, Rehfeld C, Precht Jensen EM, Ferraz C, Bösenberg E, Drieschner N, Scholz M, Hegedüs L, Paschke R.

Thyroid. 2014 Feb;24(2):305-13. doi: 10.1089/thy.2013.0278.

PMID:
23837487
14.

[BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens].

Dujardin F, Pagès JC, Collin C, de Calan L, Lecomte P, Guyétant S.

Ann Pathol. 2010 Aug;30(4):252-62. doi: 10.1016/j.annpat.2010.05.011. French.

PMID:
20837233
15.
16.

Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.

Liu S, Gao A, Zhang B, Zhang Z, Zhao Y, Chen P, Ji M, Hou P, Shi B.

Exp Mol Pathol. 2014 Oct;97(2):292-7. doi: 10.1016/j.yexmp.2014.08.005.

PMID:
25111330
17.

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN.

J Clin Endocrinol Metab. 2009 Jun;94(6):2092-8. doi: 10.1210/jc.2009-0247.

PMID:
19318445
18.

Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.

Beaudenon-Huibregtse S, Alexander EK, Guttler RB, Hershman JM, Babu V, Blevins TC, Moore P, Andruss B, Labourier E.

Thyroid. 2014 Oct;24(10):1479-87. doi: 10.1089/thy.2013.0640.

PMID:
24811481
19.

Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.

Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, Di Santo A, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F.

J Clin Endocrinol Metab. 2010 Mar;95(3):1365-9. doi: 10.1210/jc.2009-2103.

PMID:
20130073
20.

Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: a prospective case series of 960 patients.

Kleiman DA, Sporn MJ, Beninato T, Crowley MJ, Nguyen A, Uccelli A, Scognamiglio T, Zarnegar R, Fahey TJ 3rd.

Cancer. 2013 Apr 15;119(8):1495-502. doi: 10.1002/cncr.27888.

Supplemental Content

Support Center